Загрузка...
High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer
BACKGROUND: Existence of breast cancer stem cells (BCSCs) is implicated in disease relapse, metastasis, and resistance of treatment. β1,3-Galactosyltransferase 5 (B3GALT5) has been shown to be a pro-survival marker for BCSCs. However, little is known about the prognostic significance of B3GALT5 in b...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792347/ https://ncbi.nlm.nih.gov/pubmed/33413566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01381-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|